Missing content? – Request curation!
Request curation for specific Genes, variants, or PubMed publications.
Have questions, comments or suggestions? - Let us know!
Email us at : firstname.lastname@example.org
TAK-701 is a monoclonal antibody that targets HGF and prevents its binding to MET, resulting in decreased activation of HGF/MET signaling and potentially resulting in increased tumor cell death (PMID: 24019233).
|DrugClasses||HGF Antibody 4|
|Therapy Name||Drugs||Efficacy Evidence||Clinical Trials|
|Gefitinib + TAK-701||Gefitinib TAK-701||0||0|